Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

NCT05222529 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Glycopyrronium bromide 25ug
DRUG: Placebo
DRUG: Glycopyrronium bromide 12.5ug

Sponsor

Novartis Pharmaceuticals